The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


TACHOSIL



Corza Medical GmbHEU/1/04/277/1-4

Main Information

Trade NameTACHOSIL
Active SubstancesFibrinogen
Dosage FormSealant matrix
Licence HolderCorza Medical GmbH
Licence NumberEU/1/04/277/1-4

Group Information

ATC CodeB02BC Local hemostatics
B02BC30 combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued08/06/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back